We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Siemens Medical Solutions USA, a wholly owned subsidiary of Siemens AG, and
CTI Molecular Imaging announced that Siemens Medical Solutions, through its
wholly owned subsidiary MI Merger, has commenced a previously announced tender
offer for all of the outstanding shares of common stock of CTI Molecular Imaging
for $20.50 per share, net to the seller in cash.
Recom Managed Systems announced the completion of private placement financing
of $5 million with an institutional investor at $3.20 per share, with no commissions
or other fees payable.
STAAR Surgical announced it has entered into a definitive agreement to sell
4.1 million shares of newly issued common stock at a purchase price of $3.50
per share to certain institutional investors.
BioMerieux, a company in the field of in vitro diagnostics
for medical and industrial applications, announced that its BacT/ALERT 3D Microbial
Detection System will play an integral role in a single donor platelet technology
system.
Dade Behring has initiated a product recall of six lots of B1015-14 MicroScan
Rapid Pos inoculum broth to prevent health risk to patients due to potential
false antibiotic susceptibility results.
Biophan Technologies, a developer of next-generation biomedical technology,
has announced that the U.S. Patent and Trademark Office will issue on April
5 two new patents involving proprietary developments that enable magnetic resonance
imaging (MRI) of heart activity and advance the manufacture of nanoparticle
coatings for medical devices.
Xenomics, a developer of next-generation medical DNA technologies, has filed
a provisional patent in Italy for its technology enabling the detection of Transrenal-DNA
of HIV and tuberculosis through the safe and non-invasive process of urine sampling.
Applied Digital announced that VeriChip, its wholly owned subsidiary, has completed
the acquisition of eXI Wireless of Vancouver, B.C., and will now offer RFID
products through a complete array of implantable and external RFID products
for people in the healthcare and security environment.
Lumenis -- a global developer, manufacturer and seller of laser and light-based
devices for medical, aesthetic, ophthalmic, dental and veterinary applications
-- announced a new global strategy for expanding the dental segment of its medical
laser business.
MedCap announced that its AccuScan Heroin/Morphine test kit has been given experimental
status for testing purposes and is being used in several hospitals in the Beijing
area as well as being used by law enforcement agencies for testing individuals
who are known to use illegal substances.